• Please log in or register to access this feature.

SEARCH

SEARCH BY CITATION

References

  • 1
    Shapiro PA, Kornfeld DS. Psychiatric aspects of head and neck surgery. Psych Clin N Am 1987; 10: 87100.
  • 2
    Rapoport Y, Kreitler S, Chaitchik S, Algor R, Weissler K. Psychosocial problems in head-and-neck patients and their change with time since diagnosis. Ann Oncol 1993; 4: 6973.
  • 3
    Natvig K. Laryngectomies in Norway. Study No. 5: problems of everyday life. J Otolaryngol 1983; 13: 1522.
  • 4
    Silverman S. Oral cavity toxicity. In: JohnMJ, FlamMS, LeghaSS, PhillipsTL, Editors. Chemoradiation: an Integrated Approac to Cancer Treatment. Philadelphia: Lea & Febiger, 1993: 51123.
  • 5
    Humphreys B, Mathog R, Miller P, Rosen R, Muz J, Nelson R. Videofluoroscopic and scintigraphic analysis of dysphagia in the head and neck cancer patient. Laryngoscope 1987; 97: 2532.
  • 6
    Teichgraeber J, Browman J, Goepfert H. Functional analysis of treatment of oral cavity cancer. Arch Otolaryngol Head Neck Surg 1986; 112: 95965.
  • 7
    Bjordal K, Kaasa S, Mastekaasa A. Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy. Int J Oncol Biol Phys 1994; 28: 84756.
  • 8
    Aaronson NK, Ahmedzai S, Bullinger M, Crabeels D, Estape J, Filiberti A, et al. The EORTC core quality of life questionnaire: interim results of an international field study. In: OsobaD, Editor. Effect of Cancer on Quality of Life. Boston: CRC Press, 1991: 185203.
  • 9
    Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 36576.
  • 10
    List MA, Ritter-Sterr C, Lansky SB. A performance status scale for head and neck cancer patients. Cancer 1990; 66: 5649.
  • 11
    Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11: 5709.
  • 12
    Browman GP, Levine MN, Hodson DI, Sathya J, Russell R, Skingley P, et al. The head and neck radiotherapy questionnaire: a morbidity/quality of life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer. J Clin Oncol 1993; 11: 86372.
  • 13
    Hassan SJ, Weymuller EA. Assessment of quality of life in head and neck cancer patients. Head Neck 1993; 15: 48596.
  • 14
    Niezgoda HE, Pater JL. A validation study of the domains of the core EORTC quality of life questionnaire. Qual Life Res 1993; 2: 31925.
  • 15
    List MA, Ritter-Sterr C, Baker T, Colangelo L, Matz G, Pauloski BR, et al. A longitudinal assessment of quality of life in laryngeal cancer patients. Head Neck 1996; 18: 110.
  • 16
    List MA, Mumby P, Haraf D, Siston A, Malone D, Mick R, et al. Quality of life and performance outcome in survivors of concomitant chemoradiotherapy protocols for head and neck cancer. Proc Am Soc Clin Oncol 1995; 14: 297.
  • 17
    Scott CB, Stetz J, Bruner DW, Wasserman TH. Radiation Therapy Oncology Group quality of life assessment: design, analysis, and data management issues. Qual Life 1994; 3: 199206.
  • 18
    D'Antonio LL, Zimmerman GJ, Cella DF, Long S. Quality of life and functional status measures in patients with head and neck cancer. Arch Otol Head Neck Surg. in press.
  • 19
    Cella DF. Manual for the Functional Assessment of Cancer Therapy (FACT) Measurement System (version 3). Chicago: Rush Medical Center, 1994.
  • 20
    Winer BJ, Brown DR, Michels KM. Statistical Principles of Experimental Design. 3rd ed. New York: McGraw-Hill, 1991.
  • 21
    Hollander M, Wolfe DA. Nonparametric Statistical Methods. 1st ed. New York: John Wiley & Sons, 1973.
  • 22
    Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacleodCM, Editor. Evaluation of Chemotherapeutic Agents. New York: Columbia University Press, 1949: 199205.
  • 23
    Cella DF. Manual for the Functional Assessment of Cancer Therapy (FACT) Measurement System (version 2). Chicago: Rush Medical Center, 1993.
  • 24
    Cella DF, Bonomi AE, Lloyd SR, Tulsky DS, Kaplan E, Bonomi P. Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer 1995; 12: 199220.
  • 25
    Cronbach LJ, Meehl PE. Construct validity in psychological tests. Psychol Bul 1955; 52: 281302.
  • 26
    Campbell D, Fiske D. Convergent and discriminant validity by the multitrait-multimethod matrix. Psychol Bul 1959; 56: 81105.
  • 27
    Hays RD, Stewart AL. The structure of self-reported health in chronic disease patients. Psych Assess 1990; 2: 2230.
  • 28
    Ganz PA, Hirji K, Sim MS, Schag CA, Fred C, Polinsky MI. Predicting psychosocial risk in patients with breast cancer. Med Care 1993; 31: 41931.
  • 29
    Cella DF, Orofiamma B, Holland JC, Silberfarb PM, Tross S, Feldstein M, et al. Relationship of psychological distress, extent of disease, and performance status in patients with lung cancer. Cancer 1987; 60: 16617.
  • 30
    Nunnally JC. Psychometric Theory. 2nd ed. New York: McGraw Hill, 1978.
  • 31
    DeVellis RF. Scale Development: Theory and Applications. Newbury Park: Sage Publications, 1991.
  • 32
    Helmstadter GC. Principles of Psychological Measurement. New York: Appleton-Century-Crofts, 1964.
  • 33
    McCain N, Cella DF. Correlates of stress in HIV disease. West J Nurs Res 1995; 17: 14155.